A 2021 report evaluated the imaging andmonitoring of intratumoralCD8+ T lymphocytes in glioblastoma (GBM) tumors using [64Cu]-NOTA-anti-CD8 minibody PET. This evidence concerns the gene CD8A and glioblastoma.